Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
FDA-approved uses of tirzepatide (Mounjaro and Zepbound): Mounjaro is an FDA-approved dual receptor agonist used to treat blood sugar levels in individuals with type 2 diabetes mellitus
From a clinical perspective, consistent monitoring supports shared decision-making
Recent clinical studies on the highest dose of Wegovy (7.2mg) showed that the average weight loss after 72 weeks was 18.7%. 47.7% of participants were able to lose 20% or more of their initial weight
Launched in 2022, Supergut provides a range of prebiotic shakes, bars, and mixes, designed to support gut health, which will now be available at over 2,300 GNC stores and online as part of the retailers new GLP-1 Support Program
The STEP 1 trial showed an average weight loss of 14.9% of body weight at this dose over 68 weeks
US$ 27.37
US$ 20.65
US$ 23.22
US$ 26.66
